P-500 Weekly docetaxel and vinorelbine a
P-500 Weekly docetaxel and vinorelbine as second-line therapy in advanced non-small cell lung cancer
✍
Huber, R.; Schmidt, M.; Borgmeier, A.
📂
Article
📅
2005
🏛
Elsevier Science
🌐
English
⚖ 148 KB